CTLA-4 inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CTLA-4 inhibitor (unspecified), covering 2025-05-23 to 2025-05-23. Get the full timeline:
Most recent: Clinical Trial Update: PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer [Phase 1, Phase 2]